-
Mashup Score: 4
Background An antiplatelet therapy with acetylsalicylic acid (ASA) is prescribed in the prevention of cardiovascular events, but around 24% of ASA takers are re…
Source: SAGE JournalsCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
This #OpenAccess study aimed to identify the prevalence and risk factors of #acetylsalicylic acid (ASA) nonresponse in patients who underwent vascular surgery. https://t.co/T131ix3qRs